Disc Medicine Sells $720k: CFO Moves After FDA Rejection
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Explore ways to invest for quick returns to pay debt and improve your financial situation. Start making informed investment choices now!
21,539 articlesA biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
A Tuesday uptick in Edgewise Therapeutics stock topped the market, driven by an upbeat price target from a major bank...
Nvidia sits at the center of AI, and May 20 earnings looms large. This guide breaks down whether you should Nvidia st...
As healthequity (HQY) approaches 2027 earnings season, investors need a clear view of how HSAs, interest income, and ...
Duolingo has solid fundamentals even as its stock underperforms. This article breaks down why a duolingo stock recove...
Robinhood once disrupted the trading scene with free commissions. As SpaceX eyes a public debut, investors wonder if ...
A 71-year-old retired teacher faces higher Medicare costs after benefits were restored under the Social Security Fair...
Choosing the right long-term bond ETF can reshape your portfolio's risk and income. This guide compares Vanguard's VC...
Alphabet’s Q1 2026 results show stronger-than-expected search growth and record cloud momentum, challenging the AI be...
An executive move at Cirrus Logic involving 3,000 shares draws attention to insider trading signals. This article bre...
The Washington state Department of Licensing faced a public-relations setback after an AI self-service line used Engl...
Oil volatility is driving headlines as Iran tensions rise, but broad markets show unusual calm. This piece examines w...